Evaluate Safety and Efficacy of Pronavi Microcatheter for Use in Endovascular Interventions

Korábbi kezelés

• Patients who are participating in clinical trials of other drugs or medical devices;
• Patients with contraindications to the investigational device;

Más betegség

• Patients with clinical symptoms consistent with ST-elevation myocardial infarction and/or ECG changes within 12 hours before the procedure;
• Patients who are known to be intolerant to antiplatelet drugs or allergic to contrast media;
• Patients with unprotected left main coronary artery disease;

Egyéb

• Patients with in-stent occlusion;
• Women who are pregnant or lactating;
• Other patients considered by the investigators to be unsuitable for this trial.

• Age ≥ 18 years old;
• Patients with symptomatic ischemic heart disease who are suitable for non-acute percutaneous coronary intervention (PCI);
• Patients with target lesion diameter stenosis ≥ 70% (visually) or de novo coronary chronic total occlusion (CTO), or tortuous lesions, who plan to use Pronavi Microcatheter;
• Patients or their guardians who understand the purpose of the trial, voluntarily participate and sign the written informed consent, and are able to be followed up.